Experiment summary for ENCSR115YPI
doi:10.17989/ENCSR115YPI
Summary
- Status
- released
- Assay
- DNase-seq
- Biosample summary
- Homo sapiens hematopoietic multipotent progenitor cell treated with erythropoietin for 20 days, hydrocortisone succinate for 20 days, kit ligand for 20 days, interleukin-3 for 20 days
- Biosample Type
- in vitro differentiated cells
- Replication type
- unreplicated
- Treatments
- erythropoietin (CHEBI:81579) for 20 days, hydrocortisone succinate (CHEBI:31677) for 20 days, kit ligand (UniProtKB:P21583) for 20 days, interleukin-3 (UniProtKB:P08700) for 20 days
- Nucleic acid type
- DNA
- Platform
- Illumina HiSeq 2500, Illumina HiSeq 2000
Attribution
ENCODE3 project
- Lab
- John Stamatoyannopoulos, UW
- Award
- U54HG007010 (John Stamatoyannopoulos, UW)
- Project
- ENCODE
- External resources
- Date submitted
- November 15, 2017
- Date released
- May 9, 2018
- Treatment Time Series
- ENCSR963OVY
- Annotation (gkmsvm-model)
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Library |
---|---|---|---|---|
1 | 1 | Homo sapiens male adult (25 years) hematopoietic multipotent progenitor in vitro differentiated cells treated with erythropoietin for 20 days, hydrocortisone succinate for 20 days, kit ligand for 20 days, interleukin-3 for 20 days | ENCBS233BAS | ENCLB569IND |